Blood product, a method of producing the same and a method of determining the virus inactivation capacity of an inactivation treatment
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 26, 1999
Issued Date -
N/A
app pub date -
Jul 28, 1994
filing date -
Jun 20, 1991
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A blood product, exclusive of albumin, inactivated relative to infectious agents, the blood product conforming to a total virus reduction factor of at least 40, having a biological acitity of at least 50%, based on its activity prior to effecting inactivation of the infectious agents, the blood product being producible from conventional blood products and being virus-safe.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully